Revolution Medicines (RVMD) Net Margin (2019 - 2025)
Historic Net Margin for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 2670.69%.
- Revolution Medicines' Net Margin changed N/A to 2670.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 8408.98%, marking a year-over-year increase of 848322900.0%. This contributed to the annual value of 3768.28% for FY2023, which is 30653300.0% down from last year.
- Per Revolution Medicines' latest filing, its Net Margin stood at 2670.69% for Q3 2025.
- In the past 5 years, Revolution Medicines' Net Margin registered a high of 2670.69% during Q3 2025, and its lowest value of 21770.49% during Q4 2023.
- For the 4-year period, Revolution Medicines' Net Margin averaged around 2739.05%, with its median value being 716.15% (2022).
- Its Net Margin has fluctuated over the past 5 years, first soared by 26233400bps in 2022, then plummeted by -214018800bps in 2023.
- Revolution Medicines' Net Margin (Quarter) stood at 556.83% in 2021, then soared by 34bps to 368.6% in 2022, then crashed by -5806bps to 21770.49% in 2023, then surged by 112bps to 2670.69% in 2025.
- Its last three reported values are 2670.69% in Q3 2025, 21770.49% for Q4 2023, and 2570.55% during Q2 2023.